AzTrials
AzTrials

Pre-EclampsiaNCT06180811

Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women

A study testing Women's Health Delaware Food Farmacy in people with Pre-Eclampsia and Obesity, run by Christiana Care Health Services at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to conduct a pilot randomized controlled trial of a food is medicine community health worker intervention called the Women's Health Delaware Food Farmacy compared to the usual standard of care among pregnant ChristianaCare patients at risk for adverse clinical outcomes. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Pre-Eclampsia, Obesity, Gestational Diabetes
What is being tested?
Women's Health Delaware Food Farmacy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
250 participants
Where
1 siteUnited States
Study dates
2 Jan 2024to Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ChristianaCare Women's Health patient
  • 18 years or older
  • 4 to 14 weeks pregnant
  • Singleton pregnancy
  • Medicaid
  • BMI of 30 or higher
  • Reside in New Castle County

Who cannot join

  • Current diagnosis of type 1 or type 2 diabetes
  • Multiple pregnancy
  • Currently enrolled in another Community Health Worker program
  • Not able to store and prepare meals
  • Diagnosed with severe medical comorbidities that might interfere with their ability to participate in the intervention, such as severe psychiatric illness or imminent hospitalization
  • Not able to understand and communicate effectively in English or Spanish

Trial locations and contacts

1 site in 1 country.

Michelle Axe, MS, CHES contact

3024286590

michelle.axe@christianacare.org

United States1 site, 1 recruiting
  • ChristianaCare Christiana Hospital

    Newark, Delaware, 19718

    Recruiting

Other trials in United States

About this study

Official title: Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women: Addressing Social Needs and Improving Health Outcomes

The purpose of this study is to conduct a pilot randomized controlled trial of a food is medicine community health worker intervention called the Women's Health Delaware Food Farmacy compared to the usual standard of care among pregnant ChristianaCare patients at risk for adverse clinical outcomes. The pilot study has three specific aims:

Aim 1: To assess the feasibility of the Women's Health Delaware Food Farmacy and refine the program as needed

Read more

Aim 2: To determine the prevalence of and change in social needs

Aim 3: To evaluate the effectiveness of the Women's Health Delaware Food Farmacy on maternal and child health, healthcare utilization, and clinical event outcomes as well as patient-reported outcomes compared to the usual standard of care

Read the detailed description

This study is a pilot randomized controlled trial where eligible pregnant ChristianaCare patients will be identified weekly through an automated list, and patients who consent will be randomized to 1 of 2 arms (Women's Health Delaware Food Farmacy vs. usual standard of care). Participants randomized to the Women's Health Delaware Food Farmacy program arm will receive medically tailored groceries that are high in micronutrients critical for a healthy pregnancy. The food provided will be the equivalent of 10 meals per person in the household per week and will be delivered to participants weekly from enrollment to 4 weeks after giving birth. Participants will receive culinary equipment and training, recipes, and educational nutrition videos and will interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals. Participants randomized to the usual standard of care arm will continue to receive their standard of care management.

All participants will complete a questionnaire with patient-reported outcomes (i.e., food insecurity, dietary intake, health-related quality of life, and cost-related medication underuse) at baseline and postpartum and a patient experience survey postpartum related to their experiences receiving prenatal care and giving birth at ChristianaCare. In addition, maternal and child health, healthcare utilization, and clinical event outcomes will be documented for all participants via electronic health records and assessed retrospectively. Quantitative indicators related to feasibility (i.e., acceptability, demand, and implementation) will be collected such as program satisfaction, program enrollment and retention, meals provided to participants and their household, food consumption, and interactions with assigned Community Health Worker.

Aim 1: To assess the feasibility of the Women's Health Delaware Food Farmacy and refine the program as needed

H1. Primary outcomes. The investigators hypothesize that the Women's Health Delaware Food Farmacy will: (a) prove acceptable to participants, as measured by program satisfaction; (b) meet demand, as measured by project recruitment and retention, number of meals provided to participants and their household, and number of people providing food for; and (c) prove implementable, as measured by food consumption, number of Community Health Worker interactions, number of educational videos watched, number of recipes reviewed, and number of meal preparation sessions.

Aim 2: To determine the prevalence of and change in social needs

H2. Primary outcome. Social needs will be identified by administering the ChristianaCare Social Determinants of Health Screener and resource referrals will be sent on participants' behalf to support their social needs, both of which are the usual standard of care. The investigators hypothesize that social needs will be identified through the ChristianaCare Social Determinants of Health Screener, and that compared to baseline, participants at postpartum will experience reductions in their social needs. The investigators also hypothesize there will be some participants whose social needs will not be resolved due to a lack of community resources.

Aim 3: To evaluate the effectiveness of the Women's Health Delaware Food Farmacy on maternal and child health, healthcare utilization, and clinical event outcomes as well as patient-reported outcomes compared to the usual standard of care

H3a. Primary outcomes. Maternal and child health outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate improvements in maternal and child health outcomes (e.g., preeclampsia and small for gestational age) from baseline to postpartum.

H3b. Primary outcomes. Maternal and child healthcare utilization outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate reductions in maternal and child healthcare utilization outcomes (e.g., neonatal intensive care unit [NICU] admission and maternal length of stay) from baseline to postpartum.

H3c. Primary outcomes. Maternal and child clinical event outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate reductions in maternal and child clinical event outcomes (e.g., cesarean delivery and fetal death) from baseline to postpartum.

H3d. Secondary outcomes. Patient-reported outcomes: The investigators hypothesize that compared to usual standard of care, the Women's Health Delaware Food Farmacy group will demonstrate improvements in patient-reported outcomes (i.e., food insecurity, dietary intake, health-related quality of life, and cost-related medication underuse) from baseline to postpartum.

Being tested
Women's Health Delaware Food Farmacy, Usual Standard of Care
Keywords
Food is Medicine, Community Health Worker, Social Needs, Medically Tailored Groceries, Randomized Controlled Trial, Maternal and Child Health
Medical subject headings
Pre-Eclampsia, Obesity, Diabetes, Gestational, Hypertension, Pregnancy-Induced

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Women's Health Delaware Food FarmacyOther

    Participants will receive medically tailored groceries (10 meals per person in the household per week from enrollment to 4 weeks after delivery) high in micronutrients that are delivered to their homes weekly. They will also interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals.

  • Usual Standard of CareOther

    Participants will receive the usual standard of care.

Study groups in NCT06180811
Study groupRoleWhat they receive
Women's Health Delaware Food FarmacyExperimentalParticipants will receive medically tailored groceries (10 meals per person in the household per week from enrollment to 4 weeks after delivery) high in micronutrients that are delivered to their homes weekly. They will also interact weekly with their assigned Community Health Worker to address social needs and patient-centered goals.
Receives: Other: Women's Health Delaware Food Farmacy
Usual Standard of CareActive comparatorParticipants will receive the usual standard of care.
Receives: Other: Usual Standard of Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Social Determinants of Health

    Measured with ChristianaCare Social Determinants of Health Screener; Number of socials needs range from 0-11, higher scores indicate greater number of social needs

    Measured: Changes from baseline to 2-6 weeks after delivery

  2. Gestational Weight Gain

    Observed gestational weight gained

    Measured: Changes from baseline to 2-6 weeks after delivery

  3. Body Mass Index

    Observed body mass index changes

    Measured: Changes from baseline to 2-6 weeks after delivery

  4. Gestational Diabetes

    Occurrence of gestational diabetes

    Measured: From baseline to delivery

  5. Gestational Hypertension

    Occurrence of gestational hypertension

    Measured: From baseline to delivery

  6. Systolic and Diastolic Blood Pressure

    Observed systolic and diastolic blood pressure

    Measured: Changes from baseline to 2-6 weeks after delivery

  7. Preeclampsia

    Occurrence of preeclampsia and week diagnosed during pregnancy

    Measured: From baseline to 2-6 weeks after delivery

  8. Hydramnios

    Occurrence of hydramnios

    Measured: From baseline to delivery

  9. Gestational Age

    Baby's gestational age at birth

    Measured: At delivery

  10. Small for Gestational Age

    Birth weight less than 10th percentile based on gestational age

    Measured: At delivery

  11. Preterm Birth

    Preterm birth less than 37 weeks

    Measured: At delivery

  12. Fetal Macrosomia

    Birth weight greater than 90th percentile based on gestational age

    Measured: At delivery

  13. Cesarean Delivery

    Occurrence of cesarean delivery including those planned and unplanned

    Measured: At delivery

  14. Fetal Death

    Occurrence of fetal death

    Measured: From baseline to delivery

  15. NICU Admission

    Occurrence of NICU admission for any reason

    Measured: Within 48 hours after delivery

  16. NICU Length of Stay

    Number of days baby was admitted to NICU

    Measured: From NICU admission date to NICU discharge date, assessed up to 90 days

  17. Maternal Length of Stay

    Number of days hospitalized following delivery

    Measured: From delivery date to hospital discharge date, assessed up to 90 days

  18. Postpartum Admission

    Number of postpartum hospital admissions for any reason

    Measured: From delivery discharge to 90 days after

  19. Postpartum Admission Length of Stay

    Number of days hospitalized

    Measured: From postpartum admission date to hospital discharge date, assessed up to 90 days

  20. Hospital Admission

    Number of hospital admissions for any reason

    Measured: From baseline up to delivery

  21. Hospital Admission Length of Stay

    Number of days hospitalized

    Measured: From admission date to hospital discharge date, assessed up to 90 days

  22. Emergency Room Visit

    Number of emergency room visits for any reason

    Measured: From baseline to 90 days after delivery

Secondary outcomes (4)
  1. Food Insecurity

    Measured with United States Department of Agriculture Household Food Security Survey Module 6-Item Short Form, 30-day; Scores range from 0-6, higher scores indicate lower food security

    Measured: Changes from baseline to 2-6 weeks after delivery

  2. Dietary Intake

    Measured with Dietary Screener Questionnaire (DSQ-10) and six items from Dietary Screener Questionnaire (DSQ-26); Scores will be calculated using the National Cancer Institute's scoring algorithms

    Measured: Changes from baseline to 2-6 weeks after delivery

  3. Health-Related Quality of Life

    Measured with Centers for Disease Control and Prevention's Health-Related Quality of Life (HRQOL-4) scale; Number of healthy days range from 0-30, higher scores indicate greater number of healthy days

    Measured: Changes from baseline to 2-6 weeks after delivery

  4. Cost-Related Medication Underuse

    Measured with Cost-Related Medication Underuse; Scores range from 0-4, scores greater than 0 indicate cost-related medication underuse

    Measured: Changes from baseline to 2-6 weeks after delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Dec 2023
  2. Study start2 Jan 2024
  3. Primary completionNov 2025 (estimated)
  4. Study completionNov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
250 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06180811
Sponsor's protocol ID
605512
Other IDs
90XP0484
Status last verified
May 2024
First submitted
6 Dec 2023
Last updated
6 May 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Women's Health Delaware Food Farmacy in people with Pre-Eclampsia and Obesity, run by Christiana Care Health Services at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Kathleen McCallops, PhD (3024286590, kathleen.mccallops@christianacare.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Social Determinants of Health (time frame: Changes from baseline to 2-6 weeks after delivery). The study lists 22 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in